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Abstract
Introduction: Clinical evidence indicates that certain types of movement disorders are due to
psychosomatic factors. Patients with myoclonic movements are usually treated by a variety of
therapeutic agents. Autogenic training (AT), a recognized form of psychosomatic therapies, is
suitable for certain types of neurological diseases. We describe a patient with myoclonus who failed
to respond to conventional medical therapy. His symptoms were exaggerated by psychogenic
factors, especially anger.
Case presentation: A 42-year-old man was admitted to our hospital, Preventive Welfare Clinic,
for severe paroxysmal axial myoclonus of the left shoulder and abdominal muscles. The initial
diagnosis was "combination of spinal segmental myoclonus and propriospinal myoclonus". The
myoclonic movements did not occur during sleep but were aggravated by bathing, alcohol drinking,
and anger. Psychological examination indicated hostile attribution. Although considered not to be
a case of psychogenic myoclonus, a "psychogenic factor" was definitely involved in the induction of
the organic myoclonus. The final diagnosis was "combination of spinal segmental myoclonus and
propriospinal myoclonus accompanied by features of psychosomatic disorders". The patient
underwent psychosomatic therapy including AT and surface electromyography (EMG)-biofeedback
therapy and treatment with clonazepam and carbamazepine.
Results: AT and EMG-biofeedback resulted in shortening the duration and reducing the amplitude
and frequency of the myoclonic discharges.
Conclusion: Psychosomatic therapy with AT and surface EMG-biofeedback produced excellent
improvement of myoclonic movements and allowed the reduction of the dosage of conventional
medications.
Introduction
There is clinical evidence that indicates that certain types
of movement disorders are due to not only organic lesions
but also related to psychosomatic factors [1-5]. Psychoso-
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matic disorders (PSD) is a term used to describe a syn-
drome in which symptoms are aggravated by
psychological factors. Patients with myoclonic move-
ments are usually treated by a variety of therapeutic agents
such as anticonvulsants and benzodiazepines because of
their sedative effects [6-12]. On the other hand, autogenic
training (AT) is considered an effective therapy for
patients with hypertension, insomnia, headache, Ray-
naud's disease, skin disorders, anxiety [13] and pain [14].
In neurological diseases, one case report showed that
myoclonus secondary to anoxic encephalopathy was
reduced by autogenic relaxation and electromyography
(EMG) biofeedback [15]. This case is the second report of
successful improvement of myoclonus by AT.
A patient with myoclonus was referred to our hospital,
Preventive Welfare Clinic, from another hospital after fail-
ure to respond adequately to medical therapy. We did a
combination treatment of AT and biofeedback. Surface
EMG during AT was recorded to monitor myoclonic dis-
charge. AT-surface EMG therapy can provide a visual neg-
ative biofeedback effect (EMG-Biofeedback). In this
report, we describe a patient with spinal myoclonus in
whom AT-EMG-Biofeedback combination therapy
resulted in excellent improvement of symptoms.
Case Presentation
A 42-year-old man was admitted to our hospital for severe
paroxysmal axial myoclonus of the left shoulder and
abdominal muscles. The patient had been quite well and
was a member of a self-defense force team until he devel-
oped spontaneous involuntary movements about 20
times per minute. The myoclonic movement gradually
involved muscles of the left trunk, left lower extremity and
right extremities within one month. The myoclonic move-
ment did not occur during sleep but worsened upon tak-
ing a bath, drinking alcohol, and whenever the patient
was angry. The patient was first admitted to a University
hospital and diagnosed as "combination of spinal seg-
mental myoclonus and propriospinal myoclonus" [16].
The patient was treated with clonazepam (3.5 mg/day)
and carbamazepine (400 mg/day). However, this treat-
ment had no major effect on the symptoms. The condi-
tion worsened after discharge. Tapping anywhere on the
body, including the face and spine, with a neurological
hammer induced myoclonic contractions. The patient vis-
ited another medical clinic because of dissatisfaction with
the medical treatment. A few years later, the patient was
referred to our hospital, Preventive Welfare Clinic, for
consultation.
On admission, physical and neurological examinations
showed no abnormal findings apart from the myoclonic
involuntary movements. Routine laboratory tests and
MRI study of the cervical and thoracic spinal cords
showed no abnormal findings. The myoclonus consisted
of continuous rhythmic muscle contractions of the tho-
racic and abdominal muscles bilaterally, with left-side
predominance. Tapping on certain points on the body, for
example the left pectoralis major muscle or spine, with a
neurological hammer induced myoclonic discharge.
However, sound or light stimulation and elicitation of
tendon reflex did not induce the myoclonic discharge.
Medical history was negative for major accidents such as
trauma and fever, and there was no change of working cir-
cumstances after the patient developed the myoclonic
movements. Based on the description of anger-elicited
worsening of myoclonic movements, the patient under-
went a battery of psychological tests. The hysteria scale on
the Minnesota Multiphasic Personality Inventory (MMPI)
was very high (T score = 78). In the Cook-Medley Hostility
Scale, the hostility and cynicism scales were high (above
the average scale + SD). The score on the Cornel Medical
Index (CMI) was within normal range, but the hostility
scale was high.
Although clonazepam, carbamazepine, and other sedative
medications were used at relatively high doses, the treat-
ment failed to control the myoclonic movements. While
it was concluded that the myoclonus was due to organic
disease, anger/rage was associated with worsening of
symptoms and the patient seemed to have a hostile char-
acter. Psychogenic myoclonus is known as a cause of
movement disorders. Although this patient was not con-
sidered a case of psychogenic myoclonus, a "psychogenic
factor" was definitely involved in the induction of the
myoclonus. Our final diagnosis was a "combination of
spinal segmental myoclonus and propriospinal myo-
clonus accompanied by features of psychosomatic disor-
ders". Accordingly, we tried psychosomatic therapy; a
combination of AT and EMG-biofeedback therapy, to
reduce myoclonic movement and drug dosage.
Methods
Autogenic Training (AT)
AT was used for therapy as described previously [17]. First,
we described the significance of the AT effect, adaptation
to AT, and how to perform AT, using a cassette tape. The
patient started AT for 5 min, three times every day without
changing the medications.
EMG-Biofeedback
Surface EMGs of the left major pectoral muscle and
abdominal rectal muscle were recorded during AT training
in the hospital (Figure 1). The severest myoclonic move-
ments were noticed in the left major pectoral muscle and
abdominal rectal muscle. The EMG data were recorded
before and during the 5-min AT performance, and the
records were shown to the patient during feedback cogni-
tion. The recording of EMG-Biofeedback was done justBioPsychoSocial Medicine 2007, 1:18 http://www.bpsmedicine.com/content/1/1/18
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before AT training and 2, 6, 9, 13, and 16 days after AT
training. In total, AT and EMG-Biofeedback therapy were
performed for about 15 min, twice a week.
Results
Figure 2 shows the raw data of the surface EMG. The dura-
tion and amplitude of myoclonic discharge during AT
were different from those of baseline (before AT). The
duration of myoclonic discharge during AT was shorter
than that before AT in the first trial and also during the
trial at day 16 after commencement of AT training. Fur-
thermore, the amplitude recorded during AT was smaller
than that at before AT in the first trial and also during the
trial at day 16, after the commencement of AT training.
These results indicate that myoclonus discharge decreased
during AT. Comparison of AT on the first trial and at day
16 after AT training showed that both duration and ampli-
tude of the discharge were shorter and smaller in the lat-
ter, indicating that AT training for 16 days decreased the
myoclonus. Table 1 shows the duration (sec) and ampli-
tude (μV) of the myoclonic discharge before and at day 16
after AT as recorded from the left major pectoral muscle
and abdominal rectal muscle. The duration and ampli-
tude of myoclonic discharge in both muscles were signifi-
cantly lower at day 16 after the commencement of AT
training. The frequency of myoclonic discharge recorded
within 5 min also decreased progressively and signifi-
cantly from 80 to about 34 at day 16 after the commence-
ment of AT training (Figure 3).
Discussion
Psychogenic myoclonus is a recognized etiology of move-
ment disorders. The characteristic features of psychogenic
myoclonus are: 1) clinical features incongruous with
organic myoclonus, 2) evidence of underlying psychopa-
thology, 3) improvement with distraction, and 4) the
presence of incongruous sensory loss or false weakness
[18]. Since our case was not consistent with criteria 2 and
4 above, this patient was not diagnosed as psychogenic
myoclonus. In fact, this patient did not show spontaneous
remission and placebo response. However, the myo-
clonus was worsened by bathing, alcohol consumption,
and anger, and it disappeared during sleep. When psycho-
genic factors are suspected of influencing the symptoms, a
psychosomatic approach should be considered as an
optional therapy. In our case, we were able to reduce the
dosages of medications from 3.5 mg/day of clonazepam
and 400 mg/day of carbamazepine on admission to 2 mg/
day of clonazepam only on discharge. After repetitive AT
training and EMG-biofeedback therapy, the patient
emphasized that he became more calm and that he was
able to control his emotions. This awareness must have
been significant to him.
Only one report has described the use of autogenic train-
ing with EMG biofeedback therapy and that such a proto-
col reduced the myoclonus, which was induced by anoxic
encephalopathy [15]. Though myoclonus is a neurologi-
cal disease, a psychosomatic approach should be consid-
Photograph of surface EMG monitoring during autogenic training (AT) Figure 1
Photograph of surface EMG monitoring during autogenic training (AT). The patient was prepared by placing the 
electrodes on the left major pectoral and abdominal rectal muscles (green circles). The references and ground electrodes were 
placed on the right and left shoulder, respectively. Patient did AT training using a cassette tape recorder for 5 min, 3 times a 
day. During AT, the patient could watch the myoclonic jerks on the surface EMG recorder, which served as a biomechanical 
feedback.
Surface EMG monitor
Cassette tape recorderBioPsychoSocial Medicine 2007, 1:18 http://www.bpsmedicine.com/content/1/1/18
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ered as an optional therapy, especially for patients with
psychogenic factors known to enhance the symptoms.
Conclusion
Our patient with spinal myoclonus responded well to the
combination therapy of AT and surface EMG-Biofeed-
back. Such therapy reduced the duration, amplitude, and
frequency of myoclonic jerks and, consequently, we were
able to reduce the dosage of clonazepam and car-
bamazepine.
Table 1: Duration and amplitude of myoclonic discharge during 
AT performance
Left major pectoral muscle Left abdominal rectal muscle
Pre AT 16 days Pre AT 16 days
Duration (sec) 0.61 ± 0.07 0.41 ± 0.06* 0.61 ± 0.10 0.27 ± 0.08*
Amplitude (μV) 1163 ± 410 283 ± 145* 862 ± 285 159 ± 56*
Pre-AT: myoclonic discharge before AT training on the first trial
16 days: myoclonic discharge after AT training
Data are mean ± SD of all myoclonic discharges recorded within 5 min 
during AT.
*p < 0.001, compared with Pre AT (unpaired T test).
Frequency of myoclonus in 5 min Figure 3
Frequency of myoclonus in 5 min. Frequency of myo-
clonus discharges within 5 min decreased progressively and 
significantly from 80 to about 34 at day 16 after the com-
mencement of AT training.
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Representative records of surface EMG Figure 2
Representative records of surface EMG. Representative records of surface EMG from the left major pectoral (record 1) 
and left abdominal rectal muscles (record 2). Records of first trial of AT appear as Pre AT (A: before AT first trial) and During 
AT (B). Records after 16 days of AT training are marked as Before AT (C) and During AT (D). Myoclonic discharges are shown 
in red. Both the duration and amplitude of myoclonic discharges were decreased by AT after 16 days of AT training.
During AT of first trial 
During AT of 16 days after starting Before AT of 16 days after starting
record 1=⑬ᾭ䝾䇑ᄽ record 2=⑬䟿㵺䇑
Pre AT (before AT first trial)
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